NEW YORK (GenomeWeb) – Exact Sciences announced today plans for an underwritten public offering of $650 million worth of 0.3750 percent convertible senior notes due 2027. 

The company has also granted the underwriter a 30-day option to purchase up to an additional $97.5 million of the notes to cover any over-allotments. BofA Merrill Lynch is acting as sole book-running manager for the offering.